MigraineMind research summary

Therapeutic Applications of rTMS in Migraine Prophylaxis.

J Integr Neurosci | 2026

Review
AuthorsSiokas V, Marogianni C, Liampas I, Sokratous M, Tsirelis D
JournalJ Integr Neurosci
Publication year2026
PubMed ID42811900

Summary

Migraine is a significant cause of disability, especially for young adults. Many patients benefit from recent preventive therapies, but some still struggle with treatment. Repetitive Transcranial Magnetic Stimulation (rTMS) is a new option for these patients. Researchers reviewed literature to find how effective rTMS is for migraines. They searched PubMed and Scopus for studies published until March 2026. A total of 24 articles were included in their review. These articles focused on various brain areas, like the primary motor cortex and the dorsolateral prefrontal cortex. High-frequency rTMS (HF-rTMS) showed promise in reducing migraine days and pain intensity. This suggests that rTMS could be a valuable therapy for patients who do not respond to traditional medications. Overall, rTMS may offer hope for those struggling with chronic migraines and looking for new treatment options. Clinical relevance: This research indicates that rTMS could provide effective migraine prevention for patients unresponsive to standard treatments.

Related migraine research topics

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.